Log In
Print this Print this

Biosimilar erythropoietin, epoetin alfa (Abseamed)

  Manage Alerts
Collapse Summary General Information
Company Medice Arzneimittel PĆ¼tter GmbH & Co.KG
DescriptionBiosimilar version of erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation EU - Biosimilar (Treat anemia)
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today